Cost-Utility Analysis of a Six-Weeks Ganoderma Lucidum-Based Treatment for Women with Fibromyalgia: A Randomized Double-Blind, Active Placebo-Controlled Trial

References

• Wolfe F: Editorial: the status of fibromyalgia criteria. Arthritis Rheumatol 67: 330–333, 2015
   Web of Science ®Google Scholar
• Leadley RM, Armstrong N, Lee YC, Allen A, Kleijnen J: Chronic diseases in the European Union: the prevalence and health cost implications of chronic pain. J Pain Palliat Care Pharmacother 26: 310–325, 2012
   PubMedGoogle Scholar
• Rivera J, Rejas J, Esteve-Vives J, Vallejo MA, Groupo I: Resource utilisation and health care costs in patients diagnosed with fibromyalgia in Spain. Clin Exp Rheumatol 27: S39–S45, 2009
   PubMed Web of Science ®Google Scholar
• Sendur OF, Turan Y, Tastaban E, Yenisey C, Serter M: Serum antioxidants and nitric oxide levels in fibromyalgia: a controlled study. Rheumatol Int 29: 629–633, 2009
   PubMed Web of Science ®Google Scholar
• Cui XY, Cui SY, Zhang J, Wang ZJ, Yu B, Sheng ZF, Zhang XQ, Zhang YH: Extract of Ganoderma lucidum prolongs sleep time in rats. J Ethnopharmacol 139: 796–800, 2012
   Web of Science ®Google Scholar
• Bhardwaj N, Katyal P, Sharma AK: Suppression of inflammatory and allergic responses by pharmacologically potent fungus Ganoderma lucidum. Recent Pat Inflamm Allergy Drug Discov 8: 104–117, 2014
   PubMedGoogle Scholar
• Liu YJ, Du JL, Cao LP, Jia R, Shen YJ, Zhao CY, Xu P, Yin GJ: Anti-inflammatory and hepatoprotective effects of Ganoderma lucidum polysaccharides on carbon tetrachloride-induced hepatocyte damage in common carp (Cyprinus carpio L.). Int Immunopharmacol 25: 112–120, 2015
   PubMed Web of Science ®Google Scholar
• Saltarelli R, Ceccaroli P, Buffalini M, Vallorani L, Casadei L, Zambonelli A, Iotti M, et al: Biochemical characterization and antioxidant and antiproliferative activities of different ganoderma collections. J Mol Microbiol Biotechnol 25: 16–25, 2015
   Web of Science ®Google Scholar
• Kan Y, Chen T, Wu Y, Wu J, Wu J: Antioxidant activity of polysaccharide extracted from Ganoderma lucidum using response surface methodology. Int J Biol Macromol 72: 151–157, 2015
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhang Q, Deng W, Li Y, Xing G, Shi X, Du Y: Neuroprotective effect of pretreatment with Ganoderma lucidum in cerebral ischemia/reperfusion injury in rat hippocampus. Neural Regen Res 9: 1446–1452, 2014
   Web of Science ®Google Scholar
• Tran HB, Yamamoto A, Matsumoto S, Ito H, Igami K, Miyazaki T, Kondo R, Shimizu K: Hypotensive effects and angiotensin-converting enzyme inhibitory peptides of reishi (Ganoderma lingzhi) auto-digested extract. Molecules 19: 13473–13485, 2014
   Web of Science ®Google Scholar
• Meng LZ, Xie J, Lv GP, Hu DJ, Zhao J, Duan JA, Li SP: A comparative study on immunomodulatory activity of polysaccharides from two official species of Ganoderma (Lingzhi). Nutr Cancer 66: 1124–1131, 2014
   PubMed Web of Science ®Google Scholar
• Koyama K, Imaizumi T, Akiba M, Kinoshita K, Takahashi K, Suzuki A, Yano S, et al: Antinociceptive components of Ganoderma lucidum. Planta Med 63: 224–227, 1997
   PubMed Web of Science ®Google Scholar
• Hijikata Y, Yamada S: Effect of Ganoderma lucidum on postherpetic neuralgia. Am J Chin Med 26: 375–381, 1998
   PubMed Web of Science ®Google Scholar
• Li EK, Tam LS, Wong CK, Li WC, Lam CW, Wachtel-Galor S, Benzie IF, et al: Safety and efficacy of Ganoderma lucidum (lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled pilot trial. Arthritis Rheum 57: 1143–1150, 2007
   PubMed Web of Science ®Google Scholar
• Lam FF, Ko IW, Ng ES, Tam LS, Leung PC, Li EK: Analgesic and anti-arthritic effects of Lingzhi and San Miao San supplementation in a rat model of arthritis induced by Freund’s complete adjuvant. J Ethnopharmacol 120: 44–50, 2008
   PubMed Web of Science ®Google Scholar
• Collado Mateo D, Pazzi F, Dominguez Munoz FJ, Martin Martinez JP, Olivares PR, Gusi N, Adsuar JC: El Ganoderma lucidum mejora la condición física en mujeres con fibromialgia. Nutricion Hospitalaria 32: 2126–2135, 2015
   PubMed Web of Science ®Google Scholar
• Bjorkedal E, Flaten MA: Interaction between expectancies and drug effects: an experimental investigation of placebo analgesia with caffeine as an active placebo. Psychopharmacology (Berl) 215: 537–548, 2011
   Web of Science ®Google Scholar
• Bennett RM, Bushmakin AG, Cappelleri JC, Zlateva G, Sadosky AB: Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol 36: 1304–1311, 2009
   PubMed Web of Science ®Google Scholar
• Esteve-Vives J, Rivera Redondo J, Isabel Salvat Salvat M, de Gracia Blanco M, de Miquel CA: Proposal for a consensus version of the fibromyalgia impact questionnaire (FIQ) for the Spanish population. Reumatol Clin 3: 21–24, 2007
   PubMedGoogle Scholar
• McClure NS, Sayah FA, Xie F, Luo N, Johnson JA: Instrument-defined estimates of the minimally important difference for EQ-5D-5L index scores. Value Health 20: 644–650, 2017
   PubMed Web of Science ®Google Scholar
• Wolfe F, Michaud K, Li T, Katz RS: EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia. J Rheumatol 37: 296–304, 2010
   PubMed Web of Science ®Google Scholar
• Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X: Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20: 1727–1736, 2011
   PubMed Web of Science ®Google Scholar
• Willan AR: On the probability of cost-effectiveness using data from randomized clinical trials. BMC Med Res Methodol 1: 8, 2001
   Google Scholar
• De Cock E, Miravitlles M, González-Juanatey JR, Azanza-Perea JR: Valor umbral del coste por año de vida ganado para recomendar la adopción de tecnologías sanitarias en España: evidencias procedentes de una revisión de la literatura. Pharmacoecon Span Res Articles 4: 97–107, 2007
   Google Scholar
• Walters SJ, Brazier JE: Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 14: 1523–1532, 2005
   PubMed Web of Science ®Google Scholar
• Earnshaw J, Lewis G: NICE guide to the methods of technology appraisal: pharmaceutical industry perspective. Pharmacoeconomics 26: 725–727, 2008
   Web of Science ®Google Scholar
• Gómez Candela C, Cantón Blanco A, Luengo Pérez LM, Olveira Fuster G: Eficacia, coste-efectividad y efectos sobre la calidad de vida de la suplementación nutricional. Nutr Hospital 25: 781–792, 2010
   Google Scholar
• Bauer J, Capra S, Battistutta D, Davidson W, Ash S: Compliance with nutrition prescription improves outcomes in patients with unresectable pancreatic cancer. Clin Nutr 24: 998–1004, 2005
   PubMed Web of Science ®Google Scholar
• Davidson W, Ash S, Capra S, Bauer J: Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer. Clin Nutr 23: 239–247, 2004
   PubMed Web of Science ®Google Scholar
• Cai Q, Li Y, Pei G: Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural response. J Neuroinflamm 14: 63, 2017
   PubMed Web of Science ®Google Scholar
• Tsuda M: Microglia in the spinal cord and neuropathic pain. J Diabetes Investig 7: 17–26, 2016
   Web of Science ®Google Scholar